Science Explorer Interactive view Map
Company · Dübendorf · Switzerland

Helsana Group (Switzerland)

Research works
74
▼ 7% vs 2013–17
Citations
1.5k
20.8 per fractional work
Top-10% rate
19.3%
record average 16.5%
Open access
75%
world 28%

Not ranked overall: Helsana Group (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.35× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 7.66× its world share, 1 worksImmunology and Micro…Neuroscience: 0.30× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 12.52× its world share, 0 worksPharmacology, Toxico…Earth and Planetary Sciences: 0.22× its world share, 0 worksEarth and Planetary …Environmental Science: 0.18× its world share, 0 worksEnvironmental ScienceHealth Professions: 2.54× its world share, 1 worksHealth ProfessionsMedicine: 2.87× its world share, 6 worksMedicineNursing: 0.39× its world share, 0 worksNursingBusiness, Management and Accounting: 0.83× its world share, 0 worksBusiness, Management…Decision Sciences: 1.99× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.15× its world share, 0 worksEconomics, Econometr…Psychology: 2.66× its world share, 1 worksPsychologySocial Sciences: 0.39× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.5×. Every wedge is a field page.

Who are the top researchers at Helsana Group (Switzerland)?

Ranked on the composite score, Eva Blozik lead among researchers whose main affiliation is Helsana Group (Switzerland).

  1. 1 Eva Blozik Switzerland · #247,742 worldwide 259 citations · 16 works
All ranked researchers at Helsana Group (Switzerland)

Which keywords describe research at Helsana Group (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Primary Care, Epidemiology, Quality of Life, Healthcare Utilization, Public Health, Clinical Practice Guidelines, Health Outcomes and Chronic Disease Management.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology11▲ 3.7×29 topics
  2. Primary Care8▲ 27×9 topics
  3. Quality of Life6▲ 6.1×10 topics
  4. Healthcare Utilization5▲ 97×2 topics
  5. Public Health5▲ 5.2×6 topics
  6. Clinical Practice Guidelines4▲ 10×7 topics
  7. Health Outcomes4▲ 24×4 topics
  8. Cardiovascular Disease4▲ 4.7×12 topics
  9. Chronic Disease Management4▲ 35×3 topics
  10. Health Services4▲ 68×2 topics
  11. Medication Adherence3▲ 76×2 topics
  12. Quality Improvement3▲ 22×5 topics
  13. Comorbidity3▲ 44×2 topics
  14. Informed Consent3▲ 49×2 topics
  15. Chronic Conditions3▲ 81×1 topic
  16. Multimorbidity3▲ 139×1 topic
  17. Cardiovascular Disease Prevention3▲ 46×2 topics
  18. Depression3▲ 4.9×9 topics
  19. Genetic Testing3▲ 22×2 topics
  20. Chronic Disease2▲ 21×3 topics
  21. Guidelines2▲ 7.2×6 topics
  22. Interventions2▲ 39×2 topics
  23. Medical Ethics2▲ 20×1 topic
  24. Patient Compliance2▲ 164×1 topic
  25. Patient Rights2▲ 35×1 topic
  26. Treatment Adherence2▲ 164×1 topic
  27. Epidemiological Study2▲ 42×2 topics
  28. Glycemic Control2▲ 23×3 topics
  29. Chronic Diseases2▲ 11×2 topics
  30. Clinical Trials2▲ 4.8×9 topics
  31. Germany2▲ 98×1 topic
  32. Health Surveys2▲ 98×1 topic
  33. Diabetes2▲ 5.7×3 topics
  34. Ethical Considerations2▲ 7.8×2 topics
  35. Health System Reform2▲ 35×2 topics
  36. Inappropriate Medication Use2▲ 66×1 topic
  37. Life Expectancy2▲ 44×2 topics
  38. Polypharmacy2▲ 66×1 topic
  39. Economic Evaluation2▲ 18×2 topics
  40. Infectious Diseases2▲ 9.7×2 topics

Which research topics does Helsana Group (Switzerland) publish most on?

By volume in 2022–2025: Antibiotic Use and Resistance, Medication Adherence and Compliance, Chronic Disease Management Strategies and Antibiotics Pharmacokinetics and Efficacy.

  1. 1 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 1 works
  2. 2 Medication Adherence and Compliance Family Practice 0 works
  3. 3 Chronic Disease Management Strategies Epidemiology 0 works
  4. 4 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  5. 5 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  6. 6 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  7. 7 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  8. 8 COVID-19 and healthcare impacts Oncology 0 works
  9. 9 Pneumonia and Respiratory Infections Epidemiology 0 works
  10. 10 Treatment of Major Depression Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available74.9%not open25.1%

World: 28% of research is openly available.

with international co-authors31.0%domestic only69.0%

World: 19% is written across borders.

How has Helsana Group (Switzerland)'s research output changed?

Output in 2018–2022 was 7% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dübendorf

All research institutions in Dübendorf

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.